Welcome

The Neuroscience Institute at MUSC exists to create a nationally known center of neuroscience research, education and treatment by facilitating interdisciplinary collaboration in the South Carolina neuroscience community. With members drawn from departments at MUSC, the University of South Carolina, Clemson and the Greenwood Genetic Center, the Institute has grown into an invaluable resource for anyone with an interest in cutting-edge Neuroscience.

The primary focus of the Neuroscience Institute is to bridge the gap between the basic sciences and clinical sciences to provide South Carolina with the needed resources to treat and potentially cure neurodegenerative disorders. The Institute concentrates on stroke, spinal cord injury, and neurodevelopmental processes, however, provides support for research in Alzheimer’s, Parkinson’s and other neurodegenerative diseases.

Mark S. Kindy, Ph.D. is the Director of the Neuroscience Institute at MUSC, as well as Professor of Physiology and Neuroscience, Biochemistry and Molecular Biology, and Neurology. He holds the Admiral Pihl Endowed Chair for the Neuroscience Institute. He is the Director of the Stroke Program, Associate Director of the Center on Aging and Associate Director of the Spinal Cord Injury Center. He is also a Research Career Scientist at the Ralph H. Johnson VA Medical Center in Charleston.

The Institute bridges basic neurosciences with clinical neuroscience through multidisciplinary research in a number of areas including stroke, spinal cord injury, neurodevelopment, Parkinson’s disease and Alzheimer's disease. Dr. Kindy received his Ph.D. from the Boston University School of Medicine (1987), was a postdoctoral fellow at the Salk Institute (1987-89), and a faculty member at the University of Kentucky before moving to MUSC in 2002. His major research interests are understanding the role of signal transduction pathways in stroke and spinal cord injury, the mechanisms of Abeta degradation and interaction in the development and progression of Alzheimer’s disease and the development of therapeutic strategies for the treatment of neurodegenerative diseases.

Dr. Kindy has international renown for his research on the role of signaling mechanisms in ischemic injury and for the role of the RAGE receptor in amyloid diseases. Dr. Kindy has published over 100 articles. He has been member of the editorial board, of several scientific journals.